as on February 27, 2026 at 5:06 am IST
Day's Low
Day's High
0.31%
Downside
3.69%
Upside
52 Week's Low
52 Week's High
90.39%
Downside
6.58%
Upside
Check Alumis Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.5B
EPS (TTM)
-2.88
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-66.88%
Compare market cap, revenue, PE, and other key metrics of Alumis Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $3.5B | NA | NA | 0.00% | |
| BUY | $44.1B | 121.04% | 142.85 | 8.45% | |
| BUY | $123.8B | 127.26% | 31.84 | 32.94% | |
| NA | $40.8B | NA | 709.62 | 1.38% | |
| BUY | $81.6B | 74.06% | 18.62 | 31.41% |
The Alumis Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Alumis Inc investment value today
Current value as on today
₹6,32,541
Returns
₹5,32,541
(+532.54%)
Returns from Alumis Inc Stock
₹5,28,228 (+528.23%)
Dollar Returns*
₹4,313 (+4.31%)
Search interest for Alumis Inc Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 06 January
Tue, 09:17 PM
-Alumis reports successful Phase 3 trial results for envudeucitinib, leading to a 115.58% stock increase.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, ALMS stock has moved up by 284.7%
Best in 1 Year
![]()
In the last 1 year, ALMS has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Alumis Inc |
| Headquarters | 280 East Grand Avenue, South San Francisco, CA, United States, 94080 |
| CEO | Mr. Martin Babler Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. David M. Goldstein Ph.D. | Chief Scientific Officer |
Mr. Roy C. Hardiman J.D. | Chief Business & Strategy Officer |
Mr. John R. Schroer C.F.A. | Chief Financial Officer |
Mr. Philip Nunn Ph.D. | Senior VP of Pharmacology & Project Team Leader |
Dr. Jorn Drappa M.D., Ph.D. | Chief Medical Officer & Head of Research and Development |
Mr. Martin Babler Ph.D. | President, CEO & Chairman |
Ms. Sanam Pangali J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Claire Langrish Ph.D. | Senior VP & Head of Immunology and Translational Science |
Mr. Mark Bradley | Chief Development Officer |
Mr. Kolbot By Ph.D. | Senior VP & Head of Technical Operations |
Alumis Inc share price today is $28.71 as on . Alumis Inc share today touched a day high of $29.77 and a low of $28.62.
Alumis Inc share touched a 52 week high of $30.6 on and a 52 week low of $2.76 on . Alumis Inc stock price today i.e. is trending at $28.71,which is 6.18% down from its 52 week high and 940.18% up from its 52 week low.
Alumis Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Alumis Inc (ALMS) shares with as little as ₹90.899 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.99 in Alumis Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Alumis Inc share’s latest price of $28.71 as on February 26, 2026 at 11:36 pm IST, you will get 0.3483 shares of Alumis Inc. Learn more about
fractional shares .